| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11920-007-0045-3 |
| P698 | PubMed publication ID | 17915073 |
| P50 | author | Caryn Lerman | Q66360703 |
| P2093 | author name string | Robert A Schnoll | |
| Terrance A Johnson | |||
| P2860 | cites work | Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence | Q24298343 |
| Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999 | Q28217070 | ||
| Linkage and association studies in African- and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence | Q28279797 | ||
| Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine | Q28589593 | ||
| Novel genes identified in a high-density genome wide association study for nicotine dependence | Q28943515 | ||
| Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations | Q30233197 | ||
| A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans | Q30441533 | ||
| Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. | Q30442321 | ||
| A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population | Q31049251 | ||
| Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial | Q33709305 | ||
| Mimicking gene defects to treat drug dependence | Q33981489 | ||
| Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women | Q34092978 | ||
| Evaluation of sequence motifs found in scaffold/matrix-attached regions (S/MARs) | Q34141190 | ||
| Is there a common molecular pathway for addiction? | Q34463226 | ||
| Cigarette smoking among adults--United States, 2004. | Q34466572 | ||
| The genetic epidemiology of smoking | Q34478414 | ||
| Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence | Q34556213 | ||
| Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians | Q34722733 | ||
| The mu-opioid receptor gene and smoking initiation and nicotine dependence | Q35012142 | ||
| A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins | Q35030849 | ||
| Review of twin and adoption studies of adolescent substance use. | Q35200972 | ||
| Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. | Q35539136 | ||
| The genetics of smoking related behavior: a brief review | Q35558979 | ||
| The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour | Q35621339 | ||
| Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. | Q36056716 | ||
| The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial | Q36076508 | ||
| Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results | Q36154910 | ||
| Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs | Q36501908 | ||
| Overview of the pharmacogenomics of cigarette smoking | Q36708951 | ||
| A genome-wide screen for nicotine dependence susceptibility loci | Q36927570 | ||
| Association of the mu-opioid receptor gene with smoking cessation | Q40251616 | ||
| The role of CYP2A6 in the emergence of nicotine dependence in adolescents | Q40266111 | ||
| Linkage analysis of smoking initiation and quantity in Dutch sibling pairs | Q42628373 | ||
| Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial | Q42636195 | ||
| Identifying and characterizing adolescent smoking trajectories | Q42642663 | ||
| Heritability of smoking initiation and nicotine dependence | Q42660371 | ||
| A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances | Q43882794 | ||
| The DRD4 VNTR polymorphism influences reactivity to smoking cues | Q43897208 | ||
| No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation | Q43943547 | ||
| Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence | Q44070474 | ||
| Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different | Q44127823 | ||
| Pharmacogenetic investigation of smoking cessation treatment | Q44221292 | ||
| The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial | Q44344781 | ||
| The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit | Q44440052 | ||
| CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence | Q44460551 | ||
| Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial | Q44626401 | ||
| Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health | Q44739442 | ||
| Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism | Q44839164 | ||
| Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch | Q44839167 | ||
| Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study | Q44859842 | ||
| Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence | Q44877603 | ||
| Influence of genes and family environment on adult smoking behavior assessed in an adoption study | Q44886480 | ||
| Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking | Q44947671 | ||
| Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis | Q45277259 | ||
| Effect of team sport participation on genetic predisposition to adolescent smoking progression. | Q45955670 | ||
| Gender differences in determinants of smoking initiation and persistence in California twins | Q46275573 | ||
| Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. | Q46418604 | ||
| Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking? | Q46448306 | ||
| Evidence suggesting the role of specific genetic factors in cigarette smoking | Q46577802 | ||
| Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials | Q46670494 | ||
| Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. | Q46790460 | ||
| CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents | Q46793028 | ||
| Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. | Q46881158 | ||
| Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. | Q46886425 | ||
| CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation | Q46886437 | ||
| Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy | Q46886466 | ||
| Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial | Q46956137 | ||
| Smoking cessation, weight gain, and DRD4 -521 genotype | Q46982084 | ||
| The Dopamine D2 Receptor Locus as a Modifying Gene in Neuropsychiatric Disorders | Q47572104 | ||
| The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. | Q47634728 | ||
| Nicotine metabolism defect reduces smoking | Q47877657 | ||
| Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. | Q47925075 | ||
| Association between serotonin transporter gene polymorphism and smoking among Japanese males | Q48105932 | ||
| The serotonin transporter gene polymorphism is not associated with smoking behavior | Q48538356 | ||
| Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. | Q50764176 | ||
| CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. | Q51907982 | ||
| Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds. | Q51915248 | ||
| A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. | Q52285242 | ||
| Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. | Q52290758 | ||
| Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. | Q52891518 | ||
| A genome-wide search for loci contributing to smoking and alcoholism. | Q54127480 | ||
| Genomewide Linkage Scan for Nicotine Dependence: Identification of a Chromosome 5 Risk Locus | Q57318870 | ||
| DOPA decarboxylase gene is associated with nicotine dependence | Q57418917 | ||
| Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs | Q59659397 | ||
| Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking | Q73532004 | ||
| The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal | Q73571784 | ||
| The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit | Q73699436 | ||
| An association of CYP2A6 genotype and smoking topography | Q80206293 | ||
| An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health | Q82992603 | ||
| Genetic correlations between smoking initiation and smoking behaviors in a twin sample | Q83288279 | ||
| Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation | Q83961698 | ||
| Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR | Q95823983 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 349-357 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Current Psychiatry Reports | Q25245507 |
| P1476 | title | Genetics and smoking behavior | |
| P478 | volume | 9 |
| Q51761938 | "I don't have to know why it snows, I just have to shovel it!": Addiction Recovery, Genetic Frameworks, and Biological Citizenship. |
| Q28655780 | A survey on computer aided diagnosis for ocular diseases |
| Q38016946 | A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation |
| Q37008969 | APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset |
| Q36971373 | Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking |
| Q35062688 | Association of the calcyon neuron-specific vesicular protein gene (CALY) with adolescent smoking initiation in China and California |
| Q30365559 | Constitutional mechanisms of vulnerability and resilience to nicotine dependence |
| Q37216737 | Current smoking as a predictor of chronic musculoskeletal pain in young adult twins |
| Q37626678 | Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking |
| Q37280300 | Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood |
| Q28730647 | Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial |
| Q36659334 | Framing Nicotine Addiction as a "Disease of the Brain": Social and Ethical Consequences |
| Q30437713 | Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence |
| Q29417072 | Genome-wide association study of smoking behaviours in patients with COPD |
| Q38822633 | Genotype × Environment Interaction in Smoking Behaviors: A Systematic Review |
| Q34146547 | Interplay of Genetic Risk Factors and Parent Monitoring in Risk for Nicotine Dependence |
| Q45169582 | Maternal smoking during pregnancy and risks of suicidal acts in young offspring |
| Q38819832 | Narrative review of genes, environment, and cigarettes |
| Q35030489 | Pharmacogenetics and pharmacogenomics of anticancer agents. |
| Q34132214 | Pharmacogenetics of nicotine addiction: role of dopamine |
| Q34487271 | Scientific overview: 2013 BBC plenary symposium on tobacco addiction |
| Q33605769 | Sex heterogeneity in pharmacogenetic smoking cessation clinical trials |
| Q37247538 | Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent |
| Q36071415 | The media and behavioral genetics: Alternatives coexisting with addiction genetics |
| Q34715360 | Treatment of tobacco dependence: integrating recent progress into practice |
| Q33742746 | Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. |
| Q35671471 | Unwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns |
Search more.